SI2797945T1 - 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hidroksiprop-1-il)-4-metoksi-3-(fenil sulfonilmetil)tetrahidrofuran-2-il)acetaldehidni derivati in posptopek za njihovo pripravo - Google Patents
2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hidroksiprop-1-il)-4-metoksi-3-(fenil sulfonilmetil)tetrahidrofuran-2-il)acetaldehidni derivati in posptopek za njihovo pripravoInfo
- Publication number
- SI2797945T1 SI2797945T1 SI201230582A SI201230582A SI2797945T1 SI 2797945 T1 SI2797945 T1 SI 2797945T1 SI 201230582 A SI201230582 A SI 201230582A SI 201230582 A SI201230582 A SI 201230582A SI 2797945 T1 SI2797945 T1 SI 2797945T1
- Authority
- SI
- Slovenia
- Prior art keywords
- phenylsulfonylmethyl
- hydroxyprop
- tetrahydrofuran
- methoxy
- amino
- Prior art date
Links
- QQCRPBGBXNFIGE-ZZTPXLKCSA-N 2-[(2s,3s,4r,5r)-5-[(2s)-3-amino-2-hydroxypropyl]-3-(benzenesulfonylmethyl)-4-methoxyoxolan-2-yl]acetaldehyde Chemical class CO[C@H]1[C@@H](C[C@H](O)CN)O[C@@H](CC=O)[C@@H]1CS(=O)(=O)C1=CC=CC=C1 QQCRPBGBXNFIGE-ZZTPXLKCSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161581164P | 2011-12-29 | 2011-12-29 | |
| EP12863099.3A EP2797945B1 (en) | 2011-12-29 | 2012-12-24 | 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation |
| PCT/CA2012/050939 WO2013097042A1 (en) | 2011-12-29 | 2012-12-24 | 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2797945T1 true SI2797945T1 (sl) | 2016-07-29 |
Family
ID=48696142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201230582A SI2797945T1 (sl) | 2011-12-29 | 2012-12-24 | 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hidroksiprop-1-il)-4-metoksi-3-(fenil sulfonilmetil)tetrahidrofuran-2-il)acetaldehidni derivati in posptopek za njihovo pripravo |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9062020B2 (enExample) |
| EP (1) | EP2797945B1 (enExample) |
| JP (1) | JP6300030B2 (enExample) |
| CN (1) | CN104080793B (enExample) |
| AU (1) | AU2012363334B2 (enExample) |
| CA (1) | CA2860446C (enExample) |
| IN (1) | IN2014MN01521A (enExample) |
| SI (1) | SI2797945T1 (enExample) |
| WO (1) | WO2013097042A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2785687B1 (en) | 2011-11-30 | 2019-02-20 | Sandoz AG | Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene |
| US9174956B2 (en) | 2011-12-16 | 2015-11-03 | Alphora Research Inc. | Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof |
| WO2013142999A1 (en) * | 2012-03-30 | 2013-10-03 | Alphora Research Inc. | Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein |
| TW201617326A (zh) | 2014-03-06 | 2016-05-16 | Ａｌｐｈｏｒａ研發股份有限公司 | （ｓ）－１－（（２ｒ，３ｒ，４ｓ，５ｓ）－５－烯丙－３－甲氧－４－（對甲苯磺醯甲基）四氫呋喃－２－基）－３－氨基丙－２－醇之結晶衍生物 |
| WO2016003975A1 (en) | 2014-06-30 | 2016-01-07 | President And Fellows Of Harvard College | Synthesis of halichondrin analogs and uses thereof |
| US10147463B2 (en) | 2014-12-10 | 2018-12-04 | Nxp Usa, Inc. | Video processing unit and method of buffering a source video stream |
| WO2016176560A1 (en) | 2015-04-30 | 2016-11-03 | President And Fellows Of Harvard College | Chromium-mediated coupling and application to the synthesis of halichondrins |
| SMT202100416T1 (it) | 2016-03-02 | 2021-09-14 | Eisai R&D Man Co Ltd | Coniugati anticorpo-farmaco a base di eribulina e metodi di uso |
| JP6978758B2 (ja) | 2016-11-11 | 2021-12-08 | プレジデント アンド フェローズ オブ ハーバード カレッジ | パラジウム媒介ケトール化 |
| PL3606928T3 (pl) | 2017-04-05 | 2023-02-06 | President And Fellows Of Harvard College | Związek makrocykliczny i jego zastosowania |
| US9938288B1 (en) | 2017-04-05 | 2018-04-10 | President And Fellows Of Harvard College | Macrocyclic compound and uses thereof |
| SG11201912342QA (en) | 2017-07-06 | 2020-01-30 | Harvard College | Synthesis of halichondrins |
| US11498892B2 (en) | 2017-07-06 | 2022-11-15 | President And Fellows Of Harvard College | Fe/Cu-mediated ketone synthesis |
| CN111566113B (zh) | 2017-11-15 | 2024-01-09 | 哈佛大学的校长及成员们 | 大环化合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338865A (en) | 1992-03-12 | 1994-08-16 | President And Fellows Of Harvard College | Synthesis of halichondrin B and norhalichondrin B |
| US5436238A (en) | 1992-03-12 | 1995-07-25 | President And Fellows Of Harvard College | Halichondrins and related compounds |
| EP0972762B1 (en) | 1993-07-09 | 2003-10-01 | Laboratoire Theramex | Novel structural analogues of vitamin D |
| NZ508597A (en) | 1998-06-17 | 2004-01-30 | Eisai Co Ltd | Halichondrin analogs useful as anticancer and antimitotic agents |
| US7001982B2 (en) | 2003-03-31 | 2006-02-21 | Council Of Scientific And Industrial Research | Non-natural C-linked carbo-β-peptides with robust secondary structures |
| USRE46965E1 (en) | 2004-06-03 | 2018-07-24 | Eisai R&D Management Co., Ltd. | Intermediates for the preparation of analogs of Halichondrin B |
| CN108997267A (zh) * | 2004-06-03 | 2018-12-14 | 卫材R&D管理有限公司 | 用于制备软海绵素b的类似物的中间体 |
| RU2517167C2 (ru) * | 2008-04-04 | 2014-05-27 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Аналоги галихондрина в |
| EP2785687B1 (en) | 2011-11-30 | 2019-02-20 | Sandoz AG | Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene |
| US9174956B2 (en) | 2011-12-16 | 2015-11-03 | Alphora Research Inc. | Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof |
| WO2013142999A1 (en) | 2012-03-30 | 2013-10-03 | Alphora Research Inc. | Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein |
| TW201514159A (zh) | 2013-05-15 | 2015-04-16 | Alphora Res Inc | ３-（（２ｓ，５ｓ）-４-亞甲基-５-（３-氧代丙基）四氫呋喃-２-基）丙醇衍生物、其製備及對其有用的中間體 |
-
2012
- 2012-12-24 CN CN201280064611.1A patent/CN104080793B/zh not_active Expired - Fee Related
- 2012-12-24 WO PCT/CA2012/050939 patent/WO2013097042A1/en not_active Ceased
- 2012-12-24 IN IN1521MUN2014 patent/IN2014MN01521A/en unknown
- 2012-12-24 AU AU2012363334A patent/AU2012363334B2/en not_active Ceased
- 2012-12-24 JP JP2014549284A patent/JP6300030B2/ja not_active Expired - Fee Related
- 2012-12-24 CA CA2860446A patent/CA2860446C/en active Active
- 2012-12-24 EP EP12863099.3A patent/EP2797945B1/en not_active Not-in-force
- 2012-12-24 SI SI201230582A patent/SI2797945T1/sl unknown
- 2012-12-24 US US14/369,442 patent/US9062020B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2797945B1 (en) | 2016-03-16 |
| EP2797945A1 (en) | 2014-11-05 |
| AU2012363334B2 (en) | 2017-02-02 |
| US9062020B2 (en) | 2015-06-23 |
| CN104080793B (zh) | 2017-09-19 |
| WO2013097042A1 (en) | 2013-07-04 |
| IN2014MN01521A (enExample) | 2015-05-01 |
| AU2012363334A1 (en) | 2014-08-21 |
| JP6300030B2 (ja) | 2018-03-28 |
| US20150011776A1 (en) | 2015-01-08 |
| CA2860446A1 (en) | 2013-07-04 |
| CA2860446C (en) | 2017-01-10 |
| JP2015503525A (ja) | 2015-02-02 |
| EP2797945A4 (en) | 2015-06-03 |
| CN104080793A (zh) | 2014-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2797945T1 (sl) | 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hidroksiprop-1-il)-4-metoksi-3-(fenil sulfonilmetil)tetrahidrofuran-2-il)acetaldehidni derivati in posptopek za njihovo pripravo | |
| PT2707366E (pt) | Co-cristais com l-prolina e ácido cítrico de (2s,3r,4r, 5s,6r)-2-(3-((5-(4-fluorofenil)tiofen-2-il)metil)-4-metilfenil)-6- (hidroximetil tetrahidro-2h-pirano-3,4,5-triol | |
| ZA201209296B (en) | 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace) | |
| IL225672B (en) | Pharmaceutical composition comprising (2s,3s,4r,5r)-2-(4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol for inhibiting rna viral polymerase | |
| IL223423A (en) | History of 6.5 Dihydro-2 h- [1,4] Oxazin-3-Ill-Amine Used as Inhibitors in Scarlet Cell | |
| EP2566859A4 (en) | PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| HUE057571T2 (hu) | Eljárás [(5-(3-klór-fenil)-3-hidroxi-piridin-2-karbonil)-amino]-ecetsav elõállítására 5-((3-klór-fenil)-3-klór-piridin-2-il)-nitrilbõl kiindulva, és eljárás 5-(halogén-fenil)-3-halogén-piridin-2-il)-nitril-származékok elõállítására | |
| PL2796460T3 (pl) | Sześcioczłonowa pirolowa heteroarylowa pochodna pierścieniowa, sposób jej otrzymywania i zastosowania medyczne | |
| EP2687510A4 (en) | PROCESS FOR THE PREPARATION OF 2,3-DICHLORPYRIDINE | |
| IL207854A0 (en) | Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol | |
| EP2785687A4 (en) | PROCESS FOR PREPARING (3R-) 2,4-DI-ABGANBGSGRUPPEN-3-METHYLBUT-1-EN | |
| SG11201405608QA (en) | Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal with chloroacetone | |
| FR2949465B1 (fr) | Derives chromones, leur procede de preparation et leurs applications therapeutiques | |
| ZA201007611B (en) | Process for the preparation of benzo-used heteroaryl sulfamates and crystalline form of n-(((2s)-6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methylsulfamine | |
| IL220376A (en) | Polycyclic heterocyclic compounds, process for their preparation, intermediates obtained in said process and pharmaceutical compositions comprising said compounds | |
| SG11201405611SA (en) | Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal | |
| IL222351A (en) | Process for making derivatives 4,1-diethylene-di (3-pyroline) -tetrone | |
| AP2012006280A0 (en) | Synthesis process, and crystalline form of 4-ä3-ÄCis-hexahydrocyclopentaÄCÜpyrrol-2(1H)-YLÜpropoxyübenzamide hydrochloride and pharmaceutical compositions containing it. | |
| IL238931A0 (en) | Production methods for (1s,4s,5s)-4-bromo-6-oxabicyclo)[3,2,1]octane-7-one | |
| DK2163230T3 (da) | Emballage til kirurgiske hjælpemidler, især til præparationstamponer | |
| ZA201307451B (en) | Acadesine derivatives, products and compositions including same,therapeutic uses thereof and methods for synthesizing same | |
| EP2754655A4 (en) | NEW COMPOUNDS WITH ANGIOGENIC INHIBITORY EFFECT, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| IL228027A (en) | Composition of theomide, a method for the production of theomide, a method of producing a derivative of - 3, 1 - aminoethyl - 6 (r6, r4)] acetate [yl - 4 - dioxane, and a method of producing atorvastatin | |
| EP2522666A4 (en) | IMINODERIVATE, METHOD OF MANUFACTURING THEREOF AND INSECTICIDES THEREWITH | |
| EP2699560A4 (en) | 5-CARBAMOYL-ADAMANTAN-2-YL AMID DERIVATIVES, PHARMACEUTICALLY ALLOWED SALTS AND METHOD FOR THE PRODUCTION THEREOF |